After being approved by the US FDA in June, Cochlear Limited’s Nucleus 7 Sound Processor released this week is the world’s first made-for-iPhone cochlear-implant sound processor and the smallest and lightest behind-the-ear implant sound processor on the market.
The Australian company says people with a Cochlear Nucleus Implant can now stream sound directly from a compatible iPhone, iPad and iPod touch directly to their sound processor. They will also be able to control, monitor and customise their hearing on their iPhone or iPod touch through an app available on Apple’s App Store.
There are 360 million people living with disabling hearing loss worldwide, and this figure is set to more than triple to 1.2 billion by 2050.
Chris Smith, Cochlear CEO and president, says after FDA approval, people with moderate to profound hearing loss can now access mobile technology like never before.
“The approval of the Nucleus 7 Sound Processor… opens the door for people to make phone calls, listen to music in high-quality stereo sound, watch videos and have FaceTime calls streamed directly to their cochlear implant,” explains Smith.
“Technology that offers greater connectivity seeks to make life easier for people with hearing loss,” said Laurel Mahoney, clinical assistant professor of otolaryngology at the NYU Langone Health. “The advancements provided by the Nucleus 7 Sound Processor give parents more control and allow them to better monitor their child’s hearing while adults and teenagers will be able to stream music and make FaceTime calls just like their hearing friends and family.”
While launched this week, the device will go on sale in September in the US and Canada.